Unilab Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 2.50 M
as on 17-06-2024
- Company Age 46 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.86 Cr
as on 17-06-2024
- Revenue -11.47%
(FY 2023)
- Profit -12.88%
(FY 2023)
- Ebitda -44.57%
(FY 2023)
- Net Worth 8.47%
(FY 2023)
- Total Assets -5.23%
(FY 2023)
About Unilab Chemicals And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹21.86 Cr.
Smita Vora, Dipak Vora, and Rahul Vora serve as directors at the Company.
- CIN/LLPIN
U24110MH1978PTC020256
- Company No.
020256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 1978
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Unilab Chemicals And Pharmaceuticals Private Limited offer?
Unilab Chemicals And Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream, Anti Infective API, Dyes & Color Additives, Basic Dyes, Acriflavine Dry Chemical Powder, Antiseptic Gel, Lotion & Cream, Povidone Iodine.
Who are the key members and board of directors at Unilab Chemicals And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Vora  | Director | 01-Mar-2001 | Current |
| Dipak Vora | Director | 10-Jun-1994 | Current |
| Rahul Vora | Director | 12-Mar-2018 | Current |
Financial Performance of Unilab Chemicals And Pharmaceuticals.
Unilab Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.47% decrease. The company also saw a substantial fall in profitability, with a 12.88% decrease in profit. The company's net worth moved up by a moderate rise of 8.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unilab Chemicals And Pharmaceuticals?
In 2023, Unilab Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prathmesh Dyechem Private LimitedActive 31 years 4 monthsSmita Vora, Dipak Vora and 1 more are mutual person
- Zen Chemicals Private LimitedActive 21 years 3 months
Smita Vora, Dipak Vora and 1 more are mutual person
- Unilab Pharma Private LimitedActive 7 years 9 months
Smita Vora, Dipak Vora and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 17 Aug 2022 | ₹5.00 Cr | Open |
Citi Bank N.A. Creation Date: 28 Jan 2021 | ₹4.00 Cr | Open |
Sidbi Creation Date: 18 Jun 2020 | ₹5.00 M | Open |
How Many Employees Work at Unilab Chemicals And Pharmaceuticals?
Unlock and access historical data on people associated with Unilab Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unilab Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unilab Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
